NCT02783911 is a NA clinical trial of MTA in Primary Teeth, sponsored by Loma Linda University.

Who is sponsoring NCT02783911?

NCT02783911 is sponsored by Loma Linda University.

What drugs are being tested in NCT02783911?

Interventions in NCT02783911: MTA, Ferric Sulfate.

What condition does NCT02783911 study?

NCT02783911 studies Primary Teeth, Pulpotomy.

Is NCT02783911 still recruiting?

NCT02783911 is currently terminated. Last updated 11 June 2021.

Are results published for NCT02783911?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-06-11 · How we verify

NCT02783911

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies

Terminated NA Results posted Last updated 11 June 2021

What this trial tests

NA trial testing MTA in Primary Teeth in 57 participants. Terminated before completion.

Timeline

29 January 2015

Primary endpoint
14 March 2017

14 March 2017

Quick facts

Lead sponsor	Loma Linda University
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	57
Start date	29 January 2015
Primary completion	14 March 2017
Estimated completion	14 March 2017

Drugs / interventions tested

MTA — full drug profile →
Ferric Sulfate — full drug profile →

Conditions studied

Primary Teeth — all drugs for Primary Teeth →
Pulpotomy — all drugs for Pulpotomy →

Sponsor

Loma Linda University

Who can join

Adults 3 to 10, any sex, with Primary Teeth or Pulpotomy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Comparison of the Clinical Success Between Mineral Trioxide Aggregate (MTA) & Ferric Sulfate (FS) Pulpotomies in Primary Molars Primary · 1 year

At recall visits 6,9,12 months, blinded clinical examination will be completed by participating faculty members who are calibrated to clinical scaring criteria. Periapical radiographs will be taken and evaluated by 2 pediatric dentists and 1 endodontist, for presence of various pathologies. Scored based on the criteria established by Zurn and Seale 2008. Scores will be transferred to Microsoft Excel. The difference between the two materials will be analyzed using the Mann-Whiteney U test, chi-square test and Fisher's exact test. Intra- and inter-rater agreement will be measured for radiographi

Group	Value	95% CI
Mineral Trioxide Aggregate	7
Ferric Sulfate	11
Mineral Trioxide Aggregate	2
Ferric Sulfate	4

Sponsor's own description

Comparison of clinical and radiographic success between Mineral Trioxide Aggregate and Ferric Sulfate pulpotomies for primary molars. Recall appointments are completed 6 months, 9 months and 12 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pulp treatment for extensive decay in primary teeth.
Smaïl-Faugeron V, Smaïl-Faugeron V, Glenny AM, Courson F, et al · · 2018 · cited 92× · PMID 29852056 · DOI 10.1002/14651858.cd003220.pub3

Verify or expand the search:

Other trials of MTA

Trials testing the same drug.

NCT06795282 — Post Operative Sensitivity of MTA Obturation · completed
NCT06170775 — Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth · NA · unknown
NCT06170762 — Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Immature Permanent Teeth · NA · unknown
NCT05498337 — Vital Pulp Therapy With Different Materials for Young Permanent Teeth · NA · completed
NCT05419752 — Clinical Assessment of 3 Differant Obturation Sealers on Postoprative Pain and Swelling · Phase 2, PHASE3 · unknown

Other recruiting trials for Primary Teeth

Currently open trials in the same condition.

NCT07161076 — Evaluation of a 3D Printed Space Maintainer Versus the Conventional Band and Loop · NA · active not recruiting

Other Loma Linda University trials

Trials by the same sponsor.

NCT07213843 — Combined Circulatory and Dietary Interventions for Neuropathy · NA · not yet recruiting
NCT07130812 — Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain. · NA · recruiting
NCT06673342 — Effectiveness of a Nutritional Counseling Tool in Reducing the Amount and Frequency of Sugar Intake · NA · completed
NCT06445842 — Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women · NA · recruiting
NCT07396831 — Necessity of Post-operative Eye Drops · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02783911 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Loma Linda University
Last refreshed: 11 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02783911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing